PDF(Pubmed)
Abstract：
OBJECTIVE: We investigate the feasibility, safety, and clinical therapeutic effect of laparoscopic sigmoid vaginoplasty in women with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome.
METHODS: We performed a retrospective case review cohort study of 56 patients with MRKHs undergoing laparoscopic sigmoid vaginoplasty in Wuhan Union Hospital between 2000 and 2020, and all patients were followed up.
RESULTS: The median operating time was 165 min (120-420 min). The median hospital stay was 10 days (rang 7-15 days). A functional neovagina was created 11-15 cm in length and two fingers in breadth in all patients. No introitus stenosis was observed. No intra- or post-operative complications occurred. Two patients were lost to follow-up after 3 months of outpatient visits. Six patients had no intercourse and were required to wear a vaginal mold occasionally. None of the patients had complained of local irritation or dyspareunia. Patients who had post-surgery sexual intercourse were satisfied with their sexual life and the mean total Female Sexual Function Index (FSFI) score was 25.17 ± 0.63. The cosmetic results were excellent.
CONCLUSIONS: The laparoscopic sigmoid vaginoplasty can achieve the goal of making a functional neovagina. The main advantage of this surgical technique is that it is minimally invasive and that there are fewer complications post-operation. It is an acceptable procedure for patients with MRKH syndrome.
METHODS: We performed a retrospective case review cohort study of 56 patients with MRKHs undergoing laparoscopic sigmoid vaginoplasty in Wuhan Union Hospital between 2000 and 2020, and all patients were followed up.
RESULTS: The median operating time was 165 min (120-420 min). The median hospital stay was 10 days (rang 7-15 days). A functional neovagina was created 11-15 cm in length and two fingers in breadth in all patients. No introitus stenosis was observed. No intra- or post-operative complications occurred. Two patients were lost to follow-up after 3 months of outpatient visits. Six patients had no intercourse and were required to wear a vaginal mold occasionally. None of the patients had complained of local irritation or dyspareunia. Patients who had post-surgery sexual intercourse were satisfied with their sexual life and the mean total Female Sexual Function Index (FSFI) score was 25.17 ± 0.63. The cosmetic results were excellent.
CONCLUSIONS: The laparoscopic sigmoid vaginoplasty can achieve the goal of making a functional neovagina. The main advantage of this surgical technique is that it is minimally invasive and that there are fewer complications post-operation. It is an acceptable procedure for patients with MRKH syndrome.
摘要：
目的：我们研究了可行性，安全,腹腔镜乙状结肠阴道成形术治疗Mayer-Rokitansky-Kuster-Hauser综合征(MRKH)的临床疗效。
方法：我们对2000-2020年武汉协和医院56例MRKHs患者进行了回顾性病例回顾队列研究，并对所有患者进行了随访。
结果：中位手术时间为165分钟（120-420分钟）。中位住院时间为10天（7-15天）。在所有患者中创建了11-15厘米长的功能性新阴道，两个手指的宽度。未观察到颅内狭窄。无手术中或术后并发症发生。两名患者在门诊就诊3个月后失去了随访。六名患者没有性交，偶尔需要戴阴道模具。没有患者抱怨局部刺激或性交困难。术后性交的患者对性生活感到满意，女性性功能指数（FSFI）平均总分为25.17±0.63。美容结果是优异的。
结论：腹腔镜乙状结肠阴道成形术可以达到制作功能性新阴道的目的。这种手术技术的主要优点是微创，术后并发症少。对于MRKH综合征患者，这是一种可接受的手术。
方法：我们对2000-2020年武汉协和医院56例MRKHs患者进行了回顾性病例回顾队列研究，并对所有患者进行了随访。
结果：中位手术时间为165分钟（120-420分钟）。中位住院时间为10天（7-15天）。在所有患者中创建了11-15厘米长的功能性新阴道，两个手指的宽度。未观察到颅内狭窄。无手术中或术后并发症发生。两名患者在门诊就诊3个月后失去了随访。六名患者没有性交，偶尔需要戴阴道模具。没有患者抱怨局部刺激或性交困难。术后性交的患者对性生活感到满意，女性性功能指数（FSFI）平均总分为25.17±0.63。美容结果是优异的。
结论：腹腔镜乙状结肠阴道成形术可以达到制作功能性新阴道的目的。这种手术技术的主要优点是微创，术后并发症少。对于MRKH综合征患者，这是一种可接受的手术。
